HEATHER KATHERINE MOSS M.D.
Prescription History 1720023708
Obstetrics & Gynecology in Knoxville, TN
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for HEATHER KATHERINE MOSS M.D., an active Obstetrics & Gynecology specialist practicing in Knoxville, TN. Our medical registry currently tracks 3 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 50 documented patient claims. Among these therapy options, the most frequently utilized medication is Estradiol, which accounts for 23 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Prescriptions (2024)Rx (2024) | Avg Cost per FillCost / Fill | Vs. Other TN PrescribersVs. TN Avg |
|---|---|---|---|
| Estradiol | 23 | $105.44 | ▼ Less than typical |
About Estradiol: This medication is a hormone. Show more ▾ It is used by women to help reduce vaginal symptoms of menopause (such as vaginal dryness/burning/itching). These symptoms are caused by the body making less estrogen. When treating only vaginal symptoms of menopause, products applied directly inside the vagina (such as this medication) should be used first. Estrogens that are taken by mouth, absorbed through the skin, or injected may have greater risks of side effects due to more estrogen being absorbed. The 17-beta-isomer of estradiol, an aromatized C18 steroid with hydroxyl group at 3-beta- and 17-beta-position. Estradiol-17-beta is the most potent form of mammalian estrogenic steroids. In 2024, this provider wrote 23 Medicare prescriptions for Estradiol, about half the volume of the typical Tennessee prescriber of this medication (38.9). Medicare paid an average of $105.44 per fill, versus $39.55 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average TN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 70 30-Day Fills standardized to 30-day supplies 2,099 Days of Medication total across all patients in 2024 | |||
| Clobetasol Propionate | 15 | $28.88▼ below TN avg | ▼ Less than typical |
About Clobetasol Propionate: This medication is used to treat a variety of skin conditions (such as eczema, psoriasis, dermatitis, allergies, rash). Show more ▾ Clobetasol reduces the swelling, itching, and redness that can occur in these types of conditions. This medication is a very strong (super-high-potency) corticosteroid. A derivative of PREDNISOLONE with high glucocorticoid activity and low mineralocorticoid activity. Absorbed through the skin faster than FLUOCINONIDE, it is used topically in treatment of PSORIASIS but may cause marked adrenocortical suppression. In 2024, this provider wrote 15 Medicare prescriptions for Clobetasol Propionate, about a third of the volume of the typical Tennessee prescriber of this medication (39.3). Medicare paid an average of $28.88 per fill, versus $48.11 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average TN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the TN average for this medication. 15 30-Day Fills standardized to 30-day supplies 387 Days of Medication total across all patients in 2024 | |||
| Betamethasone Dipropionate | 12 | $72.03 | ▼ Less than typical |
About Betamethasone Dipropionate: This medication is used to treat a variety of skin conditions (such as eczema, dermatitis, allergies, rash). Show more ▾ Betamethasone reduces the swelling, itching, and redness that can occur in these types of conditions. This medication is a strong corticosteroid. A glucocorticoid given orally, parenterally, by local injection, by inhalation, or applied topically in the management of various disorders in which corticosteroids are indicated. Its lack of mineralocorticoid properties makes betamethasone particularly suitable for treating cerebral edema and congenital adrenal hyperplasia. (From Martindale, The Extra Pharmacopoeia, 30th ed, p724) In 2024, this provider wrote 12 Medicare prescriptions for Betamethasone Dipropionate, about half the volume of the typical Tennessee prescriber of this medication (28.3). Medicare paid an average of $72.03 per fill, versus $45.11 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average TN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 12 30-Day Fills standardized to 30-day supplies 360 Days of Medication total across all patients in 2024 | |||
About this data. The prescription history for HEATHER KATHERINE MOSS M.D. is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2024, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Obstetrics & Gynecology prescribing approach at this Knoxville, TN practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average among TN prescribers of the same medication and form, shown only when at least five prescribers contribute. Always confirm current medications and costs directly with the provider and your plan.
About the medication summaries. Drug use descriptions come from the CMS Medicare Part D Drug Spending Dashboard (2024), and substance definitions from Medical Subject Headings (MeSH) 2026, U.S. National Library of Medicine. They are summaries that do not contain all possible information about a medication and are not individual medical advice. Ask a health care professional about any medication and your specific health needs.
